Development of Method of Fructose Identification in Urine to Detect the Viral Infection - Full Text View

Purpose

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 30 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.

Condition
Human Immunodeficiency Virus


Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	The Development of Fast and Simple Method of Fructose Identification in Urine to Detect the Viral Infection in Early Stage

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS Urine and Urination

Drug Information available for: Fructose

U.S. FDA Resources

Further study details as provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:

Biospecimen Retention: None Retained

urine


Estimated Enrollment:	60
Study Start Date:	June 2011
Estimated Study Completion Date:	May 2013
Estimated Primary Completion Date:	May 2013 (Final data collection date for primary outcome measure)

Groups/Cohorts
HIV infection patient

Detailed Description:

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage.

Eligibility


Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

the person who has HIV infection

Criteria

Inclusion Criteria:

HIV infection

Exclusion Criteria:

who are in HARRT therapy

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01638312

Contacts


Contact: JihJin Tsai, MD	886-7-3121101 ext 5677	jijits@cc.kmu.edu.tw

Locations


Taiwan
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital	Recruiting
Kaohsiung, Taiwan, 807
Contact: JihJin Tsai, MD 886-7-3121101 ext 5677 jijits@cc.kmu.edu.tw
Contact: Ying Hui Wang, Master 886-7-3121101 ext 6358 try0506@gmail.com

Sponsors and Collaborators

Kaohsiung Medical University Chung-Ho Memorial Hospital

Investigators


Principal Investigator:	JihJin Tsai, MD	The Medicines Company

More Information

No publications provided


Responsible Party:	Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier:	NCT01638312 History of Changes
Other Study ID Numbers:	KMUH-IRB-20110188
Study First Received:	January 20, 2012
Last Updated:	September 28, 2012
Health Authority:	Taiwan: Department of Health

Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:


HIV, fructose

Additional relevant MeSH terms:


Acquired Immunodeficiency Syndrome HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Lentivirus Infections RNA Virus Infections	Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Virus Diseases

ClinicalTrials.gov processed this record on March 03, 2015